Tested Applications
| Positive WB detected in | A431 cells, K-562 cells, THP-1 cells, U2OS cells, C2C12 cells |
| Positive IF/ICC detected in | hTERT-RPE1 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:3000 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
30061-1-AP targets CDK10 in WB, IF/ICC, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag30365 Product name: Recombinant human CDK10 protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 190-283 aa of BC017342 Sequence: NIWPGFSKLPLVGQYSLRKQPYNNLKHKFPWLSEAGLRLLHFLFMATAGDCLESSYFKEKPLPCEPELMPTFPHHRNKRAAPATSEGQSKRCKP Predict reactive species |
| Full Name | cyclin-dependent kinase 10 |
| Calculated Molecular Weight | 283 aa, 32 kDa |
| Observed Molecular Weight | 38 kDa |
| GenBank Accession Number | BC017342 |
| Gene Symbol | CDK10 |
| Gene ID (NCBI) | 8558 |
| RRID | AB_2935507 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q15131 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Cyclin-dependent kinase 10 (CDK10) is a Cdc2-related kinase that was discovered based on its homology to the Cdc2 PSTA1RE amino acid domain (PMID: 8208557). CDK10 plays a pivotal role in the regulation of fundamental cellular processes, including cell proliferation, transcription regulation, and cell cycle regulation. It partners with cyclin M to phosphorylate substrates such as ETS2 and PKN2 in order to modulate cellular growth. Initial reports have indicated that CDK10 may act as a tumor suppressor in breast cancer (PMID: 26392360). Additional studies have demonstrated tumor suppressive and oncogenic roles for CDK10 in malignancies such as hepatobiliary cancers, gastric cancer, glioma, nasopharyngeal carcinoma, and colorectal cancer(PMID: 22326270, PMID: 29512714, PMID: 23740091, PMID: 29845196)
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for CDK10 antibody 30061-1-AP | Download protocol |
| WB protocol for CDK10 antibody 30061-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The CDK10 Polyclonal antibody (30061-1-AP) has a total of 1 citation. It appears in EMBO Reports (PMID 40155750, published 2025, Impact Factor 6). The cited study involves WB application in mouse samples and is associated with the research field of cell biology and cilia/peripheral homeostasis, specifically investigating HDAC6-mediated deacetylation of ENKD1 in regulating mitotic spindle behavior and corneal epithelial homeostasis.
| Species | Application | Title |
|---|---|---|
EMBO Rep HDAC6 deacetylates ENKD1 to regulate mitotic spindle behavior and corneal epithelial homeostasis |



